Table 3.
DSS, DMS, RQLQ(S) scores* and percent well days during the grass pollen season
| Placebo (n = 166) | Grass AIT (n = 163) | Difference | 95% CI for difference | P value | |
|---|---|---|---|---|---|
| DSS, mean (SE) |
6.06 (.40) |
5.69 (.39) |
-0.37 |
[-0.41; 1.16] |
0.3475 |
| DMS, mean (SE) |
1.47 (.22) |
1.07 (.20) |
-0.40 |
[-0.05; 0.85] |
0.0827 |
| RQLQ(S)† score, mean (SE) |
1.44 (.12) |
1.36 (.12) |
-0.08 |
[-0.16; 0.32] |
0.5293 |
| Percent well days, mean (SE) | 26.03 (3.13) | 27.44 (3.29) | 1.42 | [-8.56; 5.73] | 0.6965 |
*Scores were adjusted using the analysis of variance (ANOVA) model, with treatment group as fixed effect and pollen region as random effect. †RQLQ(S): number of observations: placebo = 840, Grass AIT = 801. AIT Allergy immunotherapy tablet, CI Confidence interval, DMS Daily medication score, DSS Daily symptom score, RQLQ(S) Rhinoconjunctivitis quality of life questionnaire with standardized activities, SE Standard error.